Abstract

2376P Pembrolizumab monotherapy following tri-modality treatment for selected patients with muscle-invasive bladder cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
Roger Li ... Kyle A Gillis
The Journal of urology | VOL. 206
Roger Li, et. al.Roger Li ... Kyle A Gillis
25 May 2021
Frequency of Tumor Recurrence: A Strong Predictor of Stage Progression in Initially Diagnosed Nonmuscle Invasive Bladder Cancer
Mototsugu Oya ... Akira Miyajima
The Journal of Urology | VOL. 185
Mototsugu Oya, et. al.Mototsugu Oya ... Akira Miyajima
17 Dec 2010
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
Thierry Lebret ... Yann Neuzillet
European Urology | VOL. 71
Thierry Lebret, et. al.Thierry Lebret ... Yann Neuzillet
30 Jun 2016
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
Michael F Sarosdy ... Joseph T Leimert
The Journal of Urology | VOL. 163
Michael F Sarosdy, et. al.Michael F Sarosdy ... Joseph T Leimert
01 Apr 2000
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers